TVTXTravere Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Travere Therapeutics, Inc. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTXThis | $5.2B#2 | — | 52.7x#2 | 10.6x#1 | 110.5%#6 | 92.1%#4 | -12.8%#5 | -25.9%#6 | -94.7%#5 | — | 262.2%#1 | — |
| MDGL | — | — | — | — | 432.1%#2 | 38.1%#5 | -31.3%#6 | -55.0%#8 | -52.5%#3 | — | — | — |
| TGTX | — | — | — | — | 87.3%#7 | 1811.1%#1 | 20.0%#3 | 76.7%#1 | 13.9%#1 | — | — | — |
| INSM | — | — | — | — | 66.7%#8 | -39.7%#9 | -205.6%#8 | -181.1%#11 | -185.1%#6 | 4#1 | -8.1%#4 | — |
| SRRK | $5.7B#1 | — | 20.5x#1 | — | — | -53.7%#11 | — | -137.0%#9 | -901.6%#7 | — | — | — |
| APGE | — | — | — | — | — | -40.5%#10 | — | — | — | — | 250.9%#2 | — |
| PTGX | — | — | — | — | -89.4%#11 | -147.3%#13 | -343.6%#9 | -19.9%#4 | -33.5%#2 | — | 154.2%#3 | — |
| SMMT | — | — | — | — | — | -387.8%#14 | — | -171.4%#10 | — | — | — | — |
| UTHR | — | — | — | — | 10.6%#9 | 11.7%#6 | 46.9%#2 | 22.6%#2 | — | — | — | — |
| PRAX | — | — | — | — | -100.0%#12 | -65.6%#12 | — | -21.5%#5 | — | — | — | — |
| ARWR | — | — | — | — | 23258.2%#1 | 99.7%#3 | 11.9%#4 | -0.3%#3 | — | — | — | — |
| COGT | — | — | — | — | -65.0%#10 | -28.6%#7 | -4235.3%#11 | -54.1%#7 | -81.2%#4 | — | — | — |
| BBIO | — | — | — | — | 126.3%#4 | — | -104.2%#7 | — | — | — | — | — |
| PTCT | — | — | — | — | 114.5%#5 | 288.0%#2 | 50.1%#1 | — | — | — | — | — |
| CYTK | — | — | — | — | 376.6%#3 | -33.2%#8 | -695.4%#10 | — | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice